Teva to nominate new directors

|About: Teva Pharmaceutical Indust... (TEVA)|By:, SA News Editor

In the latest step toward remaking the company, Teva Pharmaceutical (NYSE:TEVA) will seek to overhaul its board by nominating four new directors.

Among their first orders of business would be picking a new chief executive.

"We are evolving the board to meet new challenges both within Teva and the business" of generic drugs, aid Sol Barer, the board's chairman.

Subscribe for full text news in your inbox